The Executive Desk: July Executive Board Meeting
Hal C. Lawrence III, MD, Executive Vice President and CEO
For the August Executive Desk, I’d like to focus on a few key items from ACOG’s July Executive Board Meeting, which was held in Washington, DC, on July 15, 2016. The Executive Board meets quarterly to discuss ACOG business, programs, and operational plans. The meeting was called to order by ACOG’s 67th president, Thomas Gellhaus, MD.
We discussed the Republican party’s health care platform (starts on page 36) to ensure we are well versed to participate in any upcoming legislative discussions should that party win the 2016 presidential election. We reviewed ACOG’s successful efforts on dealing with opioid use disorder legislation, highlighted Dr. Christopher Zahn’s activity with Congress regarding Zika, and discussed the need for women’s health representation at MACPAC. We announced the improved access to postpartum LARC with clarification from the Center for Medicaid and CHIP services.
We reviewed the outstanding activity in the Alliance for Innovation in Maternal Health (AIM) program. This HRSA-funded program is growing beyond expectations. The program, which provides a community and resources to significantly reduce severe maternal morbidity and maternal mortality, now covers 10 states with 13 more on the way. The AIM program is also being extended to Malawi on a trial basis. ACOG is again hosting a course provided by the American Society on Addiction Medicine (ASAM) for women's health care physicians in August on Prescribing Buprenorphine for opioid addiction treatment. Activities with the payment transitions group were discussed. With the repeal of SGR last year and the coming on board of MACRA this year, ACOG stands ready to assist members in the transition. And look for the SCOPE program, which provides in-person patient safety review services leading to certification for office-based practices, to provide more flexibility as a potential web-based self-assessment tool.
HRSA has funded a five-year grant to update, confirm and expand the IOM recommendations for women’s health care. Through the Women’s Preventive Services Initiative (WPSI), ACOG will lead this effort with trusted partners.
Committee on Bylaws
Committee Chair Martin Tucker, MD, reviewed bylaw changes that effect the executive board:
- All national elected board positions, national committee appointments, and subspecialty representatives to the executive board will now take office at the conclusion of the business meeting at the Annual Clinical and Scientific Meeting, not after inauguration of the president.
- The ACOG executive vice president and CEO and the ABOG executive director will no longer have voting rights on the executive board.
- Terms of office for all nonpresidential national officers, young physicians at large and fellows at large on the board, and all district and section officers will now be two years instead of three.
- The JFCAC vice chair will be added to the board.
Enjoy this issue of ACOG Rounds.